- Report
- December 2025
- 250 Pages
Global
From €4212EUR$4,799USD£3,643GBP
- Report
- February 2026
- 150 Pages
Global
From €5222EUR$5,950USD£4,517GBP
- Report
- January 2026
- 180 Pages
Global
From €3112EUR$3,545USD£2,691GBP
€3457EUR$3,939USD£2,990GBP
- Report
- February 2026
- 250 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- May 2026
- 192 Pages
Global
From €5135EUR$5,850USD£4,441GBP
- Report
- January 2026
- 185 Pages
Global
From €3950EUR$4,500USD£3,416GBP
- Report
- October 2025
- 139 Pages
Global
From €3510EUR$3,999USD£3,036GBP
- Report
- October 2025
- 160 Pages
Global
From €2947EUR$3,358USD£2,549GBP
€3467EUR$3,950USD£2,999GBP
- Report
- August 2025
- 165 Pages
United States
From €3467EUR$3,950USD£2,999GBP
- Report
- November 2025
- 142 Pages
Global
From €4257EUR$4,850USD£3,682GBP
- Report
- September 2025
- 85 Pages
United States
From €3072EUR$3,500USD£2,657GBP
- Report
- August 2025
- 383 Pages
Global
From €4345EUR$4,950USD£3,758GBP
- Report
- August 2025
- 120 Pages
Global
From €2326EUR$2,650USD£2,012GBP
- Report
- January 2026
- 192 Pages
Global
From €3112EUR$3,545USD£2,691GBP
€3457EUR$3,939USD£2,990GBP
- Report
- August 2025
- 193 Pages
Global
From €3112EUR$3,545USD£2,691GBP
€3457EUR$3,939USD£2,990GBP
- Report
- January 2026
- 280 Pages
Global
From €3171EUR$3,613USD£2,742GBP
€3730EUR$4,250USD£3,226GBP
- Report
- June 2025
- 150 Pages
Global
From €5222EUR$5,950USD£4,517GBP
- Report
- July 2025
- 228 Pages
Global
From €2194EUR$2,500USD£1,898GBP
- Report
- February 2026
- 250 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- February 2026
- 250 Pages
Global
From €3941EUR$4,490USD£3,409GBP

The Peptide Therapeutic market is a subset of the Proteomics industry, which focuses on the study of proteins and their functions. Peptide Therapeutics are a type of drug that are composed of short chains of amino acids, and are used to treat a variety of diseases. These drugs are typically used to target specific proteins in the body, and can be used to treat conditions such as cancer, diabetes, and autoimmune diseases. Peptide Therapeutics are often used in combination with other drugs, such as chemotherapy, to maximize their effectiveness.
The Peptide Therapeutic market is highly competitive, with many companies developing and marketing these drugs. Some of the major players in the market include Amgen, Merck, Novartis, Pfizer, and Sanofi. Other companies such as AbbVie, AstraZeneca, and Eli Lilly are also active in the market. Show Less Read more